Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Reksa Dana Indeks Mandiri ETF LQ45 (XMLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hetzer Medical Indonesia Tbk. vs Reksa Dana Indeks Mandiri ETF LQ45 — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume), while Reksa Dana Indeks Mandiri ETF LQ45 trades at Rp700 (market cap 8.63B, 16K 24h volume). The key difference: Hetzer Medical Indonesia Tbk. is far larger — about 14.7× Reksa Dana Indeks Mandiri ETF LQ45's market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 16K). Which is the better fit depends on your goals.
| MEDS | XMLF | |
|---|---|---|
Market Cap | 126.56B | 8.63B |
Volume | 319.74M | 16K |
Lot | 3.2M | 160 |
Turnover | 27.4B | 11.43M |
Average Price | 85.68 | 714.34 |
Value | 27.4B | 11.43M |
Indicative Equilibrium Price | 82 | — |
Indicative Equilibrium Volume | 12.79K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →
